KIMS Hospitals has released its investor presentation for the third quarter of fiscal year 2026. The presentation covers the unaudited standalone and consolidated financial results for the quarter and nine months ending December 31, 2025. Details on the company’s performance, strategy, and expansion plans are included. KIMS continues its growth trajectory with a vision for affordable, quality healthcare.
Vision and Strategy
KIMS Hospitals is driven by a vision to provide affordable quality care and achieve the best clinical outcomes. A core component of their mission is to be the best place for doctors and employees, fostering a patient-centric approach and leveraging modern medical technology. This includes a growth-driven career approach with a strong academic and research orientation.
Financial Highlights
For Q3 FY26, KIMS Hospitals reported operating revenue of ₹9,977 million, a 3.9% increase QoQ and 29.2% YoY. Total revenue reached ₹10,029 million, marking a 26.9% YoY growth. EBITDA stood at ₹2,041 million.
For the nine-month period, the operating revenue was ₹28,300 million, up by 26.4% YoY.
Operational Performance
IP volume for Q3 FY26 reached 61,139, while OP volume totaled 585,491. The Average Revenue Per Occupied Bed (ARPOB) was reported at ₹46,341, and Average Revenue Per Patient (ARPP) was ₹164,232.
Expansion and Future Growth
KIMS Hospitals continues to focus on strategic levers for future growth, including consistent growth, affordable healthcare models, transplant programs, and cutting-edge medical technology. A key component is strategic doctor partnerships. The hospital aims to add 2000+ beds through Greenfield, acquisitions, and O&M opportunities. Further expansion is planned, including increased capacity in existing facilities and new locations.
Key Accomplishments
KIMS has received many awards and accreditations and continues to expand facilities and services.
Source: BSE
